title: Fructose-induced hypertension in Wistar-Kyoto rats: interaction with moderately high dietary salt.
abstract: We investigated the effects of 4% fructose plus moderately high salt (MHS) (4% NaCl) treatment on tissue aldehyde conjugates, platelet cytosolic free calcium ([Ca2+]i), renal morphology, and systolic blood pressure (SBP) in Wistar-Kyoto rats, and whether these effects were reversible (R) after withdrawal of treatment. At age 7 weeks, rats were divided into 4 groups: NS group, given normal salt (NS) diet (0.7% NaCl) for 18 weeks; NS+F(R) group, NS diet and fructose in water for 14 weeks, then 4 weeks fructose withdrawal; MHS+F group, NS diet and fructose for 6 weeks, then MHS diet and fructose for 12 weeks; and MHS+F(R) group, NS diet and fructose for 6 weeks, then MHS diet and fructose for 8 weeks, then MHS and fructose withdrawal for 4 weeks. SBP in the NS+F(R) group increased during fructose treatment, but normalized within 1 week of withdrawal. Tissue aldehyde conjugates and platelet [Ca2+]i were normal at completion. Adverse renal vascular changes did not reverse to normal and were similar to those of the salt plus fructose-treated groups. This may have implications for future development of hypertension. MHS did not cause any additional increase in SBP or associated tissue alterations when added to fructose treatment. However, the SBP and tissue changes persisted even after discontinuation of treatment. The fructose and salt combination may result in long-lasting vascular alterations leading to hypertension.
authors.affiliation: Department of Medicine and Laboratory Medicine Health Sciences Centre, Memorial University of Newfoundland, St. John's, NL A1B 3V6, Canada. svasdev@mun.ca
authors.forename: Sudesh
authors.initials: S
authors.lastname: Vasdev
authors.forename: Vicki
authors.initials: V
authors.lastname: Gill
authors.forename: Sushil
authors.initials: S
authors.lastname: Parai
authors.forename: Vereesh
authors.initials: V
authors.lastname: Gadag
mesh_terms: D000447:Aldehydes / Q000378:metabolism; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D005632:Fructose; D006321:Heart / Q000033:anatomy & histology / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051381:Rats; D011921:Rats, Inbred WKY; D017673:Sodium Chloride, Dietary / Q000494:pharmacology*
chemical_list: D000447:Aldehydes; D017673:Sodium Chloride, Dietary; D005632:Fructose; D002118:Calcium